Glycoproteomic Laboratory, Parasitology Department, Institute of Biomedical Science II, University of Sao Paulo, Sao Paulo, Brazil.
Glycoproteomic Laboratory, Parasitology Department, Institute of Biomedical Science II, University of Sao Paulo, Sao Paulo, Brazil; School of Natural Sciences, Macquarie University, Sydney, NSW, Australia.
Adv Clin Chem. 2024;120:169-190. doi: 10.1016/bs.acc.2024.04.008. Epub 2024 May 3.
Developing molecular strategies to manipulate gene expression in trypanosomatids is challenging, particularly with respect to the unique gene expression mechanisms adopted by these unicellular parasites, such as polycistronic mRNA transcription and multi-gene families. In the case of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas Disease, the lack of RNA interference machinery further complicated functional genetic studies important for understanding parasitic biology and developing biomarkers and potential therapeutic targets. Therefore, alternative methods of performing knockout and/or endogenous labelling experiments were developed to identify and understand the function of proteins for survival and interaction with the host. In this review, we present the main tools for the genetic manipulation of T. cruzi, focusing on the Clustered Regularly Interspaced Short Palindromic Repeats Cas9-associated system technique widely used in this organism. Moreover, we highlight the importance of using these tools to elucidate the function of uncharacterized and glycosylated proteins. Further developments of these technologies will allow the identification of new biomarkers, therapeutic targets and potential vaccines against Chagas disease with greater efficiency and speed.
开发操纵原生动物基因表达的分子策略具有挑战性,特别是对于这些单细胞寄生虫采用的独特基因表达机制,例如多顺反子 mRNA 转录和多基因家族。在克氏锥虫(T. cruzi)的情况下,克氏锥虫是恰加斯病的病原体,缺乏 RNA 干扰机制进一步复杂化了对寄生虫生物学的理解以及生物标志物和潜在治疗靶点的功能遗传研究。因此,开发了替代的敲除和/或内源性标记实验方法,以鉴定和理解与生存和与宿主相互作用相关的蛋白质的功能。在这篇综述中,我们介绍了用于克氏锥虫遗传操作的主要工具,重点介绍了该生物体中广泛使用的成簇规律间隔短回文重复 Cas9 相关系统技术。此外,我们强调了使用这些工具阐明未表征和糖基化蛋白质功能的重要性。这些技术的进一步发展将以更高的效率和速度鉴定新的生物标志物、治疗靶点和潜在的抗恰加斯病疫苗。